| Interdigitating Dendritic Cell Sarcoma studied in …STUDIED_INderived38 of 38show fewer |
|---|
| → studied in | NCT07443137Phase 1 · not yet recruiting CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study) · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778212NA · recruiting Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCL · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570823Phase 3 · recruiting A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03316573Phase 2 · suspended Pembrolizumab in Neoplasms or Lymphomas · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744724Phase 2 · not yet recruiting Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744737Phase 2 · not yet recruiting Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07744750Phase 2 · not yet recruiting Pirtobrutinib+Sonrotoclax（PS) Regimen in the Treatment of B-Cell Lymphoma · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07749365Phase 2 · recruiting Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07680933Phase 2 · recruiting Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07677813Phase 2 · not yet recruiting Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06985576enrolling by invitation Long-term Study to Evaluate Safety and Persistence of GF-CART01 · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06026644completed Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07552324Phase 2 · not yet recruiting Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07511114Phase 3 · not yet recruiting A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06481826recruiting Glofitamab in Chinese Patients With R/R DLBCL · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07472621not yet recruiting Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389356NA · not yet recruiting Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCL · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07288879Phase 2 · recruiting DALY II Japan/MB-CART2019.1 for DLBCL · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07326371Phase 2 · not yet recruiting Glofitamab Combined With CAR-T Therapy in R/R DLBCL · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05950802Phase 1 · recruiting Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07255963Phase 2 · recruiting Pirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07231250Phase 2 · not yet recruiting Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712810Phase 1 · recruiting Q702 for the Treatment of Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05621096Phase 1 · active not recruiting Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592846completed FERtility After Therapy With Intensive Lymphoma in Young Women: LNH-03 1B, LNH-03 2B, LNH-07 3B, GAINED Follow-up · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07066436early Phase 1 · not yet recruiting ImmunoMRI for Assessment of Tumor-associated Macrophages · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07057765recruiting Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07034508Phase 2 · not yet recruiting A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1 · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06891157Phase 2 · recruiting Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06151080Phase 2 · recruiting Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158399Phase 2 · recruiting AZA Combined With RCHOP in P53-mutated DLBCL. · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06452446active not recruiting Telehealth-based Symptom Management for Veterans Treated With Selinexor · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06734078active not recruiting An Italian Multicenter Retrospective Observational Study to Assess the Clinical Characteristics and the Outcome of Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin Plus Rituximab (± Bendamustine) Under Named Patient Programme · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06026488recruiting Real-World Study of DLBCL With Different Genetic Subtypes · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05641428Phase 2 · recruiting Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06526065recruiting Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict) · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06299553recruiting Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND) · condition mapped ONTOLOGY_EXACT · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01593696Phase 1 · completed Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma · condition mapped PROBABILISTIC · 38 trials mapped (34 active) | — | — | Interdigitating Dendritic Cell Sarcoma | 1 | Observed | clinicaltrials | graph → |